Denmark

Danish food innovator MATR Foods signed a €20 million loan agreement with the European Investment Bank (EIB) to expand production of plant-based meat-alternatives. The EIB funding, supported by the InvestEU initiative of the European Commission, will enable MATR to build a first-of-its-kind plant for the production of a new generation of clean label plant-based meat alternatives and unlock further investments in product research and development.

In 2023, the European Investment Bank Group (EIB Group) signed €1.44 billion in new financing contracts for projects in Denmark – equal to 0.38% of Danish gross domestic product. The EIB Group funded 20 projects in the country, ranging from investments for energy company Ørsted by the European Investment Bank, to SME financing via the European Investment Fund.

Danish biotechnology company Zealand Pharma A/S has signed a loan facility of €90 million with the European Investment Bank (EIB), the long-term lending institution of the European Union owned by the Member States. Zealand focuses on the discovery and development of innovative peptide-based medicines, and will use the EIB funding to advance its differentiated research and development pipeline of clinical-stage product candidates targeting obesity, rare diseases and chronic inflammation.